Kinneer, Krista
Flynn, Matt
Thomas, Suneetha B.
Meekin, John
Varkey, Reena
Xiao, Xiaodong
Zhong, Haihong
Breen, Shannon
Hynes, Paul G.
Fleming, Ryan
Bezabeh, Binyam
Chen, Cui (Tracy)
Wetzel, Leslie
Chen, Ruoyan
Dimasi, Nazzareno http://orcid.org/0000-0001-9379-1646
Tai, Yu-Tzu
Anderson, Kenneth C.
Herbst, Ronald
Howard, Philip W.
Hurt, Elaine M.
Tice, David A.
Article History
Received: 6 June 2018
Revised: 27 August 2018
Accepted: 3 September 2018
First Online: 12 October 2018
Compliance with ethical standards
:
: Y-TT declares that she has no conflict of interest. KCA is the scientific founder of Oncopep and C4 Therapeutics and serves on the advisory boards of MedImmune, Bristol-Myers Squibb, Gilead and Millenium Pharmaceuticals. PWH is an employee of Spirogen and has stock and/or stock interests in AstraZeneca. All other authors are employees of MedImmune or were employees of MedImmune while they were involved with this work and have stock and/or stock interests in AstraZeneca.